DK175840B1 - Behandling af osteoporose - Google Patents

Behandling af osteoporose Download PDF

Info

Publication number
DK175840B1
DK175840B1 DK199100727A DK72791A DK175840B1 DK 175840 B1 DK175840 B1 DK 175840B1 DK 199100727 A DK199100727 A DK 199100727A DK 72791 A DK72791 A DK 72791A DK 175840 B1 DK175840 B1 DK 175840B1
Authority
DK
Denmark
Prior art keywords
calcium
potassium
osteoporosis
hydrogen carbonate
urine
Prior art date
Application number
DK199100727A
Other languages
Danish (da)
English (en)
Other versions
DK72791A (da
DK72791D0 (da
Inventor
R Morris Curtis Jr
Anthony Sebastian
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of DK72791D0 publication Critical patent/DK72791D0/da
Publication of DK72791A publication Critical patent/DK72791A/da
Application granted granted Critical
Publication of DK175840B1 publication Critical patent/DK175840B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199100727A 1988-10-21 1991-04-19 Behandling af osteoporose DK175840B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26085688A 1988-10-21 1988-10-21
US26085688 1988-10-21
PCT/US1989/004727 WO1990004402A1 (en) 1988-10-21 1989-10-20 Treatment of osteoporosis
US8904727 1989-10-20

Publications (3)

Publication Number Publication Date
DK72791D0 DK72791D0 (da) 1991-04-19
DK72791A DK72791A (da) 1991-05-14
DK175840B1 true DK175840B1 (da) 2005-03-29

Family

ID=22990921

Family Applications (2)

Application Number Title Priority Date Filing Date
DK199100727A DK175840B1 (da) 1988-10-21 1991-04-19 Behandling af osteoporose
DK199100726A DK175841B1 (da) 1988-10-21 1991-04-19 Behandling af hypertension

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK199100726A DK175841B1 (da) 1988-10-21 1991-04-19 Behandling af hypertension

Country Status (13)

Country Link
US (1) US5804204A (ko)
EP (3) EP0720855A3 (ko)
JP (2) JP2843146B2 (ko)
KR (2) KR0178033B1 (ko)
AT (1) ATE145825T1 (ko)
AU (2) AU634988B2 (ko)
CA (2) CA2001124C (ko)
DE (2) DE68913311T2 (ko)
DK (2) DK175840B1 (ko)
HU (2) HU212106B (ko)
IL (2) IL92076A (ko)
WO (2) WO1990004402A1 (ko)
ZA (2) ZA898018B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
WO2003086423A1 (en) * 2002-04-05 2003-10-23 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
EP1350515A1 (en) * 2002-04-05 2003-10-08 Btg International Limited Low-dose potassium supplementation for the prevention and treatment of hypertension
US20040202726A1 (en) * 2003-04-10 2004-10-14 Deshay Samuel L. Topical blood pressure composition
US10251909B2 (en) * 2007-02-09 2019-04-09 Board Of Regents, The University Of Texas System Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension
US20090022853A1 (en) * 2007-07-16 2009-01-22 Conopco, Inc., D/B/A Unilever Beverage
MX2010008625A (es) * 2008-02-06 2010-09-14 Campbell Soup Co Metodos y composiciones para reducir el contenido de sodio en productos alimenticios.
ATE537710T1 (de) * 2008-09-05 2012-01-15 Unilever Nv Getränke, die kalium enthalten
CN114272263A (zh) * 2022-01-10 2022-04-05 伍永田 一种用于治疗高血压疾病的水配方

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611730A (en) * 1950-09-02 1952-09-23 Simth Kline & French Lab Medical preparation for reducing the body level of sodium
GB1195381A (en) * 1967-04-28 1970-06-17 Arthur H Cox & Company Ltd Pharmaceutical Compositions Comprising Potassium and Chlorine
US3639585A (en) * 1968-03-29 1972-02-01 Res Inst Medicine Chem Method of preventing corticosteroid-induced adverse effects on bon and compositions useful in said method
US3541208A (en) * 1968-09-10 1970-11-17 Arcom Holding Corp Relief of arthritis with a soluble silicate and a soluble polyphosphate
US3921804A (en) * 1974-05-09 1975-11-25 William W Tester Medication dispensing package
SU858830A1 (ru) * 1974-10-23 1981-08-30 Институт медико-биологических проблем Средство дл лечени нарушений ритма сердца
SU946545A1 (ru) * 1978-05-04 1982-07-30 Институт Медико-Биологических Проблем Министерства Здравоохранения Ссср Способ восполнени калиевого дефицита в ткан х
FR2432869A1 (fr) * 1978-08-08 1980-03-07 Armour Montagu Laboratoire Compositions pour le traitement de l'osteoporose associant la calcitonine et le phosphore
US4289750A (en) * 1978-10-16 1981-09-15 Kopp Klaus F Therapy of conditions which may be associated with altered renal function and dosage forms therefor
US4405596A (en) * 1978-10-16 1983-09-20 Helbig Joachim W Pharmaceutical preparations for and treatment procedures involving increasing plasma bicarbonate level
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
JPH0619063B2 (ja) * 1986-04-09 1994-03-16 日本エステル株式会社 粉体塗料用樹脂組成物

Also Published As

Publication number Publication date
DK72791A (da) 1991-05-14
WO1990004402A1 (en) 1990-05-03
EP0440738A4 (en) 1991-08-28
IL92075A (en) 1995-07-31
CA2001123A1 (en) 1990-04-21
IL92076A0 (en) 1990-07-12
DK72691A (da) 1991-04-22
JP2948247B2 (ja) 1999-09-13
DE68913311T2 (de) 1994-05-26
AU4515489A (en) 1990-05-14
KR900701288A (ko) 1990-12-01
ZA898017B (en) 1990-12-28
HUT57989A (en) 1992-01-28
IL92075A0 (en) 1990-07-12
DE68927519D1 (de) 1997-01-16
CA2001124C (en) 2000-01-18
CA2001124A1 (en) 1990-04-21
AU635231B2 (en) 1993-03-18
ZA898018B (en) 1990-12-28
HUT63058A (en) 1993-07-28
EP0720855A2 (en) 1996-07-10
DK72791D0 (da) 1991-04-19
CA2001123C (en) 2000-01-18
WO1990004403A1 (en) 1990-05-03
EP0440738B1 (en) 1996-12-04
KR0178033B1 (ko) 1999-03-20
EP0720855A3 (en) 1998-07-08
DK72691D0 (da) 1991-04-19
EP0461111A1 (en) 1991-12-18
JPH04501724A (ja) 1992-03-26
US5804204A (en) 1998-09-08
KR0163583B1 (ko) 1998-12-01
JPH04501419A (ja) 1992-03-12
KR900701287A (ko) 1990-12-01
DK175841B1 (da) 2005-03-29
HU896567D0 (en) 1991-07-29
HU896889D0 (en) 1991-07-29
HU208923B (en) 1994-02-28
JP2843146B2 (ja) 1999-01-06
AU4622089A (en) 1990-05-14
EP0461111B1 (en) 1994-02-23
EP0461111A4 (en) 1991-07-25
DE68927519T2 (de) 1997-04-03
AU634988B2 (en) 1993-03-11
DE68913311D1 (de) 1994-03-31
HU212106B (en) 1996-02-28
IL92076A (en) 1995-08-31
EP0440738A1 (en) 1991-08-14
ATE145825T1 (de) 1996-12-15

Similar Documents

Publication Publication Date Title
Conn et al. Licorice-induced pseudoaldosteronism: hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity
DK175840B1 (da) Behandling af osteoporose
WO1995017889A1 (fr) Composition therapeutique utile pour traiter l'hyperparathyroidie d'un patient en dialyse artificielle
US6027737A (en) Treatment for osteoporosis using potassium salts
US8216614B2 (en) Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
US5496569A (en) Simultaneous treatment of osteoporosis and hypertension with potassium bicarbonate
RU2396076C1 (ru) Средство, уменьшающее степень острой алкогольной интоксикации (опьянения) и обладающее антипохмельным действием, биологически активная добавка, фармацевтическая композиция, лекарственное средство и способ получения
US20220016062A1 (en) Powders containing a buffer salt and an amino acid, reconstitution of such a powder into a nutritional product, and methods of using such a nutritional product
JP3441411B2 (ja) コレステロール低減化ペプチド
AU2020267068A1 (en) Novel pharmaceutical composition
JP4059934B2 (ja) コレステロール低減化ペプチド
JP2003238590A (ja) コレステロール低減化ペプチド
JPH08508503A (ja) 骨粗しょう症の治療のための方法及び組成物

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK